海外の脳生検のベスト医師 — ページ4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

ヤン・セヨン医師は、Naeun病院の脳神経外科部長を務める脳神経外科医です。脳梗塞、脳出血、脳動脈瘤、もやもや病、頸動脈狭窄症、血管性めまい、頭部外傷を専門としています。

韓国カトリック大学医学部を卒業し、同大学で医学修士号を取得しました。カトリック医療センターでインターンシップと脳神経外科のレジデンシーを修了。その後、臨床フェローシップを修了し、議政府聖母病院で臨床助教授を務めました。

京畿北部地域外傷センターでスタッフ脳神経外科医として勤務した経験があります。また、G-SAM病院の脳神経外科部長も務めました。

Wutthiphong Wilaiwarangkun医師は、タイ医学評議会（ライセンス番号 ว.49590）の認定を受けた神経内科医です。チョンブリー県シラチャのパシフィック・ガーデン病院内にあるニューロ・メド・クリニックに勤務しています。神経疾患の相談、診断、長期ケアを提供しています。

ワライラック大学で医学博士号を取得。タイ保健省医療サービス局傘下のラジャヴィティ病院にて、タイ神経学会の専門医認定を取得しています。ラジャヴィティ病院は認定を受けた三次医療機関であり、タイ全土から脳血管疾患、てんかん、神経変性疾患、神経筋疾患の症例を多数受け入れています。

以前はサトゥーン病院で神経内科専門医として勤務。急性脳卒中、救急神経内科、入院および外来診療を担当していました。地方での幅広い経験を現在の診療に活かしています。

ウルヴィ・サマザデ医師は、イズミルにあるメディカルポイント国際病院の神経内科医です。てんかん、パーキンソン病、多発性硬化症の治療を専門としています。ガジ大学およびドクズ・エイリュル大学病院で研修を受けました。サマザデ医師は、国際パーキンソン病・運動障害学会の会員です。

• ボツリヌス毒素注射やIVIG療法を用いて神経症状の管理を行います。
• アルツハイマー病、片頭痛、運動障害などの複雑な疾患を治療します。
• 欧州神経学会の会員です。
• JCI認定を受けたトルコのメディカルポイント国際病院に勤務しています。

サミュエル・モスコヴィッチ医師は、ハダサ医療センターの脳神経外科専門医です。複雑な脳疾患に関する67本の査読付き論文の共著者です。

• 神経サルコイドーシスおよび神経鞘腫（脳生検を必要とすることが多い希少疾患）の専門家
• 繊細な脳組織を治療するための血管内手術を専門とする
• 6つの特定の神経疾患の管理において、臨床医の同僚から高く評価されている
• エルサレムの主要な教育病院で診療を行っている

エラ・シマイ・ゼンギン医師は、イズミルにあるJCI認定のメディカルポイント・インターナショナル病院の神経内科医です。米国神経学会および国際パーキンソン病・運動障害学会の会員です。ゼンギン医師は、アルツハイマー病、てんかん、多発性硬化症などの神経疾患を治療しています。

• アポモルヒネポンプや片頭痛ワクチンなどの専門的な治療法を使用しています。
• 慢性片頭痛や運動障害に対してボツリヌス毒素注射を行っています。
• 複雑な神経変性疾患、パーキンソン病、脳卒中の合併症を治療しています。
• 欧州神経学会の会員です。

ホセ・コーエンはハダッサ医療センターの脳神経外科部門を率いています。正確な神経学的診断のために、脳生検や専門的な血管造影を行っています。

• 脳腫瘍や脳動脈瘤などの複雑な疾患を治療
• 成人および小児の脳神経外科の両方を専門とし、多様な症例に対応
• 医療開発に対する「Healthcare Manpower Development Plan」賞を受賞
• 米国心臓病学会およびシンガポール医学アカデミーのフェロー
• インターベンション医学と患者の安全性に関する研究に積極的に取り組む研究者

アンドリー・キー医師は、ハダッサ医療センターの脳神経外科部長を務めています。医学への貢献が認められ、国際脳神経外科学会連盟から名誉メダルを授与されました。

• 複雑な脳腫瘍の摘出および頭蓋底手術を専門としています。
• 成人および小児患者の両方に対して脳生検を実施します。
• サイバーナイフおよびガンマナイフシステムを使用し、標的を絞った非侵襲的な腫瘍治療を行います。
• オックスフォード大学およびクリーブランドクリニックで脳神経外科の研修を受けました。
• 元ロイヤルメルボルン病院脳神経外科部長。

メフメット・ベシル・スルメ医師は、トルコのエスキシェヒル市立病院の脳神経外科医です。小児脳神経外科と複雑な脳腫瘍の摘出を専門としています。スルメ医師はイタリアのローマで小児脳神経外科の国際フェローシップを修了しました。専門分野において40件以上の引用実績を持つ科学論文を執筆しています。

• 開頭手術、水頭症のシャント手術、脳嚢胞摘出術を行います。
• アーノルド・キアリ奇形や脊柱管狭窄症を外科的手法で治療します。
• パーキンソン病に対する脳深部刺激療法および脊髄刺激療法の専門家です。
• 3Dプリントされた型を使用して、カスタマイズされた頭蓋形成術を行います。

Turkan Ozturk Topcu博士は、イスタンブールのビルニ大学病院の臨床腫瘍医です。彼女は米国のMDアンダーソンがんセンターと専門的な関係を維持しています。乳がん、肺がん、消化器がんの治療を専門としています。Topcu博士はESMOとASCOの両方の会員です。

• カナダのサニーブルック・オデットがんセンター乳腺クリニックでフェローシップを修了。
• 肝臓がん、膵臓がん、婦人科がんを含む幅広い疾患を治療。
• 米国のモフィットがんセンターなどの主要機関で臨床職を歴任。
• トルコのTEMOS認定施設であるビルニ大学病院に勤務。

アタカン・トプチュ医師は、イスタンブールのメディポル・アジバデム地区病院の腫瘍内科医です。肺がん、乳がん、大腸がんを含む固形腫瘍の治療を専門としています。トプチュ医師は准教授であり、50本以上の査読付き科学論文を発表しています。医学誌『BMC Cancer』の編集委員を務めています。

• 免疫療法、分子標的療法、老年腫瘍学ケアの専門知識。
• がん関連の栄養失調、悪液質、サルコペニアの治療。
• 欧州臨床腫瘍学会（ESMO）の正会員。
• 高度な腫瘍治療を専門とするJCI認定病院に勤務。

メフメット・トンゲ医師は、メディポル・アジバデム病院の定位・機能神経外科医です。運動障害に対する脳深部刺激療法およびMRIガイド下集束超音波治療を専門としています。トンゲ医師はオランダのマーストリヒト大学で脳深部刺激療法のフェローシップを修了しました。パーキンソン病、痙縮、慢性疼痛などの複雑な疾患を治療しています。

• 30以上の国際的な出版物と12の医学書章の著者。
• 欧州神経外科学会連合の4年間のトレーニングサイクルを修了。
• ガンマナイフ放射線外科および運動障害に対する電極留置の専門家。
• ダヴィンチ・ロボットシステムを備えたJCI認定病院に勤務。

メフメット・アキフ・ゴグシュゲレン医師は、イスタンブールのAvicenna国際病院の脳神経外科医です。数千件の手術実績があり、低侵襲な顕微鏡下手術を専門としています。ゴグシュゲレン医師は、患者の安全を確保するために小さな切開で結果を出すことに注力しています。イスタンブールで最高ランクのISO認定病院で診療を行っています。

• 脳腫瘍摘出術、椎間板切除術、椎弓切除術を行います。
• 脊柱管狭窄症、下垂体腺腫、脳嚢胞などの複雑な疾患を治療します。
• MS（多発性硬化症）、ALS（筋萎縮性側索硬化症）、自閉症、脊髄損傷に対して幹細胞治療を行います。
• 術後の安心のため、患者様に直接モバイルアクセスを提供しています。

Buse Cagla Ari博士は、メディポル・アジバデム地区病院の神経内科准教授です。運動障害、認知症、慢性頭痛を専門としています。Ari博士は、国際パーキンソン病・運動障害学会の会員です。片頭痛および運動障害に対するボツリヌス毒素注射を専門としています。

• 神経ブロックとボツリヌス毒素を使用して、複雑な頭痛障害を治療します。
• パーキンソン病、てんかん、アルツハイマー病を治療します。
• ポリソムノグラフィーや睡眠潜時検査を含む診断的な睡眠研究を実施します。
• イスタンブールにある50の専門診療科を持つJCI認定病院で勤務しています。